Skip to main content

Table 1 Participant baseline demographic and clinical characteristics

From: Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial

Characteristic No. (%) p value
Integrated stepped alcohol treatment (n = 47) Treatment as usual (n = 46)
Men 44 (93.6) 45 (97.8) 0.62
Race 1.00
 White 9 (19.2) 9 (19.6)
 Black 37 (78.7) 36 (78.3)
 Other 1 (2.1) 1 (2.2)
Hispanic 2 (4.4) 4 (8.7) 0.43
Age, mean (SD), y 59.1 (9.6) 56.5 (9.8) 0.19
Education 0.94
 High school or less 17 (36.2) 17 (37.0)
  > High school 30 (63.8) 29 (63.0)
Married or domestic partner 11 (23.4) 7 (15.2) 0.85
Employment statusa 0.90
 Employed 17 (36.2) 19 (41.3)
 Retired/disability 21 (44.7) 19 (41.3)
 Unemployed or unable to work 8 (17.0) 7 (15.2)
 Controlled environment 1 (2.1) 0 (0)  
 Student 0 (0) 1 (2.2)  
AUDIT-C score, mean (SD)b 5.45 (2.26) 5.50 (2.38) 0.91
Other substance use, past 30 daysc
 Smoke cigarettes 24 (51.1) 19 (43.2) 0.45
 Cannabis 9 (19.2) 11 (23.9) 0.58
 Cocaine 2 (4.3) 3 (6.5) 0.68
 Heroin 0 (0) 0 (0) NA
 Prescription opioids 1 (2.1) 3 (6.5) 0.36
Comorbid conditions and biomarkers
 Hepatitis C co-infectiond 12 (25.5) 13 (28.3) 0.77
 FIB-4 score > 1.45e, f 36 (76.6) 32 (69.6) 0.44
 Depressive symptomsg 7 (14.9) 7 (15.2) 0.97
HIV related measures
 VACS Index, median (range)f,h 33 (0,93) 28 (6,68) 0.34
 Detectable HIV viral loadf,i 17 (36.2) 15 (32.6) 0.72
 CD4 cell count, cells/mm3, median (range)f 542 (112,1427) 537 (109,1255) 0.91
  1. aEmployment status, employment during past 3 years: assessed based on the Addiction Severity Index Lite-CF[54]
  2. bAlcohol Use Disorders Identification Test-Consumption (AUDIT-C) scores range from 0 to 12
  3. cOther substance use, past 30 days: assessed based on item “Do you know smoke cigarettes (as of 1 month ago)?” and the Addiction Severity Index Lite-CF[54]
  4. dHepatitis C coinfection status—based on positive antibody and detectable HCV RNA viral load
  5. eFIB-4 score—a noninvasive measure of liver fibrosis calculated based on aspartate aminotransferase, alanine aminotransferase, and platelets with scores greater than 1.45 concerning for liver fibrosis
  6. fLaboratory testing performed within 30 days prior to randomization date
  7. gDepressive symptoms determined using the Patient Health Questionnaire (PHQ)-9 with score > 9 defined as having depressive symptoms[55]
  8. hVACS index—validated measure of morbidity and mortality risk [40]
  9. iDetectable HIV viral load—defined as ≥ 50 copies/mL